English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

1. the actual role of tumour markers in the follow-up for breast cancer; 2. the use of tumour markers as an indicator of positron emission tomography (PET) execution and as a predictor of PET positivity; 3. the diagnostic accuracy of tumour markers, PET or PET/computed tomography (CT), and their combination; 4. the clinical and therapeutic impacts of tumour markers and nuclear medicine imaging; 5. the future prospective for breast cancer follow-up.

Tumour Markers and Molecular Imaging with FDG PET/CT in Breast Cancer: Their Combination for Improving the Prediction of Disease Relapse